V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10324397 | 10068840 | null | null | null | 2017-09-16 | 2017-09-30 | CYCLOPHOSPHAMIDE | null | null | CYCLOPHOSPHAMIDE | 101632972 |
| 10324771 | 10068841 | 1.68 | null | Palliative (P) | 2019-08-15 | 2019-08-23 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | GEMCITABINE | 100514049 |
| 10324882 | 10068842 | 1.78 | 77 | Palliative (P) | null | 2022-03-26 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100530100 |
| 10324889 | 10068843 | 1.78 | 93 | 03 | 2022-02-01 | 2022-02-10 | GDP | 02 | N | NIRAPARIB | 101262419 |
| 10325540 | 10068845 | 1.51 | 65.6 | null | null | 2020-01-25 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100900869 |
| 10326909 | 10068848 | null | null | Adjuvant (A) | 2019-05-31 | 2019-06-22 | Cyclophosphamide Weekly IV | null | null | CYCLOPHOSPHAMIDE | 100048468 |
| 10327920 | 10068850 | 1.77 | null | null | 2022-05-02 | 2022-05-05 | CARBOPLATIN + VINORELBINE | 02 | null | CARBOPLATIN + VINORELBINE | 101454638 |
| 10328154 | 10068852 | 1.82 | 68.6 | Palliative (P) | 2017-11-28 | 2017-11-28 | CTD Attenuated (Thalidomide 50mg) | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100504596 |
| 10328328 | 10068854 | 1.77 | 81.4 | null | 2022-02-12 | 2022-02-12 | Cabazitaxel | 02 | null | CABAZITAXEL | 100134591 |
| 10329035 | 10068856 | 1.71 | 68.8 | Palliative (P) | 2019-12-04 | 2019-12-23 | Palbociclib | 02 | N | PALBOCICLIB | 100904689 |
| 10329739 | 10068859 | 1.56 | 70.7 | null | null | 2022-03-15 | CYCLOPHOSPHAMIDE + MESNA | 02 | null | CYCLOPHOSPHAMIDE | 100954058 |
| 10329756 | 10068860 | 1.76 | 73.5 | Curative (C) | 2022-01-16 | 2022-01-17 | Melphalan oral | 02 | N | MELPHALAN | 101160073 |
| 10330398 | 10068862 | 1.78 | 61 | Adjuvant (A) | 2021-12-13 | 2021-12-15 | Cyclophosphamide oral | 02 | N | CYCLOPHOSPHAMIDE | 100291968 |
| 10330577 | 10068863 | 1.66 | 64.2 | Palliative (P) | 2016-08-15 | 2017-05-26 | Cyclophosphamide Weekly PO | 02 | N | CYCLOPHOSPHAMIDE | 100782587 |
| 10330979 | 10068864 | 1.71 | 72 | Curative (C) | null | 2020-09-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | IPILIMUMAB + NIVOLUMAB | 100452643 |
| 10331112 | 10068865 | 1.83 | 60.2 | null | 2018-08-27 | 2018-09-01 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 101041789 |
| 10331273 | 10068866 | 1.69 | 76.9 | Palliative (P) | 2019-02-12 | 2019-07-29 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 101694661 |
| 10331403 | 10068867 | 1.78 | 77.6 | Palliative (P) | 2021-01-09 | 2021-01-22 | Chlorambucil | 02 | N | CHLORAMBUCIL | 100152013 |
| 10331998 | 10068870 | 1.82 | 70 | Palliative (P) | 2022-03-19 | 2022-04-17 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100211258 |
| 10332234 | 10068871 | 1.85 | 83.9 | null | 2018-08-28 | 2022-03-12 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | null | null | CISPLATIN + VINORELBINE | 101818860 |
| 10332249 | 10068872 | null | 99 | Palliative (P) | 2020-01-29 | 2020-02-01 | BUSULFAN | 02 | null | ACALABRUTINIB | 100366434 |
| 10332384 | 10068873 | 1.74 | 63 | Palliative (P) | 2020-10-08 | 2020-10-08 | Azacitidine | 02 | N | AZACITIDINE | 100402818 |
| 10332419 | 10068874 | 1.58 | 77.4 | 03 | 2019-12-06 | 2019-12-06 | FLUOROURACIL | 02 | N | CAPECITABINE + IRINOTECAN | 101529331 |
| 10332422 | 10068875 | 1.53 | 76 | Curative (C) | 2018-06-19 | 2018-07-23 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101626166 |
| 10333023 | 10068877 | 1.66 | 77.4 | null | 2019-06-15 | 2020-03-03 | Methotrexate intrathecal | 02 | null | METHOTREXATE | 100192278 |
| 10333855 | 10068880 | 1.66 | 64 | Adjuvant (A) | null | 2018-11-28 | Palbociclib | 02 | N | PALBOCICLIB | 100221537 |
| 10334459 | 10068882 | 1.82 | 102.8 | null | 2020-08-30 | 2020-09-04 | Azacitidine | 02 | null | AZACITIDINE | 100347002 |
| 10334507 | 10068883 | 1.7 | 102.8 | null | 2019-03-23 | 2019-06-14 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 100200605 |
| 10334840 | 10068884 | 1.7 | 69.05 | Palliative (P) | null | 2018-02-27 | Cisplatin + Radiotherapy | 02 | N | DABRAFENIB | 101617369 |
| 10335799 | 10068886 | 1.69 | null | null | 2020-03-01 | 2022-01-31 | CHLORAMBUCIL + OBINUTUZUMAB | N | null | CHLORAMBUCIL + OBINUTUZUMAB | 100110642 |
| 10336195 | 10068890 | 1.6 | 48 | Palliative (P) | 2019-06-22 | 2019-06-22 | Busulfan Oral | 02 | null | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 100606987 |
| 10336205 | 10068891 | 1.8 | 89.3 | Palliative (P) | 2018-09-30 | 2018-09-30 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101294257 |
| 10336803 | 10068893 | 1.68 | 78.5 | null | 2019-12-05 | 2019-12-20 | Trifluridine + Tipiracil | null | null | TIPIRACIL + TRIFLURIDINE | 100623473 |
| 10337202 | 10068895 | null | 61.4 | null | 2018-02-26 | 2018-03-25 | Cetuximab 14 day | 02 | null | BUSULFAN | 100709955 |
| 10337954 | 10068897 | 1.57 | 46.6 | Curative (C) | 2021-08-11 | 2021-09-28 | Chlorambucil | 02 | N | CHLORAMBUCIL | 100774395 |
| 10338059 | 10068898 | 1.74 | 58 | Palliative (P) | 2018-06-24 | 2018-06-25 | Carboplatin + Liposomal Doxorubicin | 02 | N | ACALABRUTINIB | 100219080 |
| 10338187 | 10068899 | 1.4 | 86.55 | null | 2017-07-11 | 2017-08-15 | CVP R | 02 | null | CETUXIMAB | 101086184 |
| 10338492 | 10068900 | 1.82 | 85.5 | Palliative (P) | 2021-07-17 | 2021-07-28 | null | 02 | N | NIRAPARIB | 100307331 |
| 10342041 | 10068904 | 1.83 | 70 | Palliative (P) | 2020-06-17 | 2020-09-10 | Cyclophosphamide oral | null | N | CYCLOPHOSPHAMIDE | 100515927 |
| 10343942 | 10068905 | 1.67 | 58.6 | Palliative (P) | 2018-10-24 | 2019-02-18 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100348848 |
| 10344617 | 10068906 | 1.15 | 91 | Palliative (P) | 2022-03-23 | 2022-04-12 | Chlorambucil | 02 | N | CHLORAMBUCIL | 101711570 |
| 10344794 | 10068908 | 1.75 | 61.1 | Palliative (P) | 2018-08-19 | 2020-10-22 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101238011 |
| 10344832 | 10068909 | null | 91 | null | 2019-01-03 | 2019-01-05 | AFATINIB | 02 | null | AFATINIB | 101849123 |
| 10344995 | 10068910 | 1.71 | 66 | Adjuvant (A) | 2019-01-18 | 2019-01-19 | Palbociclib | 02 | N | PALBOCICLIB | 100687509 |
| 10345183 | 10068911 | 1.66 | 74 | null | 2021-12-20 | 2022-05-20 | Cabazitaxel | 02 | null | CABAZITAXEL | 101118914 |
| 10346155 | 10068912 | null | 78.5 | null | 2019-10-04 | 2019-10-04 | MELPHALAN | 02 | null | MELPHALAN | 101144118 |
| 10347790 | 10068913 | null | 84.5 | Palliative (P) | 2016-12-06 | 2020-07-14 | PERTUZUMAB + TRASTUZUMAB | 02 | N | DABRAFENIB | 100122337 |
| 10348764 | 10068914 | 1.63 | 97.8 | null | 2022-02-07 | 2022-02-14 | PERTUZUMAB + TRASTUZUMAB | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100430393 |
| 10349266 | 10068915 | 1.72 | 85 | null | 2019-07-25 | 2019-08-08 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | GEMCITABINE | 101278660 |
| 10354581 | 10068917 | 1.66 | 87 | Curative (C) | 2019-02-17 | 2019-02-24 | Melphalan IV High dose | 02 | N | MELPHALAN | 100820369 |